The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Brain Volume Changes in First-Episode Schizophrenia: A 1-Year Follow-up Study
Abstract
BACKGROUND: Imaging studies of patients with schizophrenia have demonstrated that brain abnormalities are largely confined to decreases in gray matter volume and enlargement of the lateral and third ventricles. Global gray matter volume has been reported to progressively decrease in childhood-onset and chronic schizophrenia. Global gray matter volumes have not been examined longitudinally in patients with first-episode schizophrenia. One would expect global gray matter to decrease progressively, particularly in first-episode patients, because clinical deterioration is greatest in the early stages of the disease. METHODS: Patients with first-episode schizophrenia who had taken antipsychotic medication for 0 to 16 weeks (n = 34) and matched healthy comparison subjects (n = 36) were included in the study. For all subjects, magnetic resonance imaging scans of the whole brain were obtained at inclusion and after 1 year (mean [SD], 12.7 [1.1] months). Outcome was measured 2 years after inclusion. To compare morphological changes over time between patients and healthy comparison subjects, multiple repeated-measures analyses of variance were conducted with intracranial volume as a covariate. Outcome and cumulative antipsychotic medication were related to changes in patients' brain volumes. RESULTS: Total brain volume (-1.2%) and gray matter volume of the cerebrum (-2.9%) significantly decreased and lateral ventricle volume significantly increased (7.7%) in patients. The decrease in global gray matter volume significantly correlated with outcome and, independently of that, with higher cumulative dosage of antipsychotic medication. CONCLUSIONS: The loss of global gray matter in schizophrenia is progressive, occurs at an early stage of the illness, and is related to the disease process and antipsychotic medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Brain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552
Talairach, J., Tournoux, P., & Rayport, M. (1988) · Thieme eBooks · Cited by 5,058
A nonparametric method for automatic correction of intensity nonuniformity in MRI data
Sled, J. G., Zijdenbos, A. P., & Evans, A. C. (1998) · IEEE Transactions on Medical Imaging · doi:10.1109/42.668698 · Cited by 4,731 · cited 1×
“All images were coded to ensure blindness for subject identification and diagnosis; scans were put into Talairach frame (no scaling)(49) and corrected for inhomogeneities in the magnetic field.(50) Intracranial, total brain, cerebral gray and white matter, lateral ventricle, third ventricle, and cerebellum volumes wer…”
MethodMultimodality image registration by maximization of mutual information
Maes, F., Collignon, A., Vandermeulen, D., Marchal, G., & Suetens, P. (1997) · IEEE Transactions on Medical Imaging · doi:10.1109/42.563664 · Cited by 4,547
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,901
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Meta-analysis of regional brain volumes in schizophrenia
Wright, I. C., Rabe-Hesketh, S., Woodruff, P. W. R., David, A. S., Murray, R. M., & Bullmore, E. T. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.16 · Cited by 1,662
Cited by
Perkins, D. O., Gu, H., Boteva, K., & Lieberman, J. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1785 · Cited by 1,346
Differential aging of the brain: Patterns, cognitive correlates and modifiers
Raz, N., & Rodrigue, K. M. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.07.001 · Cited by 1,195
Ho, B.-C., Andreasen, N. C., Ziebell, S., Pierson, R., & Magnotta, V. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.199 · Cited by 971
Regionally Localized Thinning of the Cerebral Cortex in Schizophrenia
Kuperberg, G. R., Broome, M. R., McGuire, P. K., David, A. S., Eddy, M., Ozawa, F., Goff, D., West, W. C., Williams, S. C. R., van der Kouwe, A. J. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.9.878 · Cited by 843
Steen, R. G., Mull, C., Mcclure, R., Hamer, R. M., & Lieberman, J. A. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.6.510 · Cited by 832
Antipsychotic Drug Effects on Brain Morphology in First-Episode Psychosis
Lieberman, J. A. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.361 · Cited by 801
Regionally localized thinning of the cerebral cortex in schizophrenia
Kuperberg, G. R., Broome, M., McGuire, P. K., David, A. S., Eddy, M., Ozawa, F., Goff, D., West, W. C., Williams, S. R., van der Kouwe, A. W., et al. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)81127-1 · Cited by 759
Size of burden of schizophrenia and psychotic disorders
Rössler, W., Joachim Salize, H., van Os, J., & Riecher-Rössler, A. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.04.009 · Cited by 741
Pantelis, C. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi034 · Cited by 573
Miyamoto, S., Miyake, N., Jarskog, L. F., Fleischhacker, W. W., & Lieberman, J. A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.47 · Cited by 573
Ho, B.-C., Andreasen, N. C., Nopoulos, P., Arndt, S., Magnotta, V., & Flaum, M. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.6.585 · Cited by 536
Murray, R. M., Sham, P., Van Os, J., Zanelli, J., Cannon, M., & McDonald, C. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.03.002 · Cited by 516
Hedman, A. M., van Haren, N. E. M., Schnack, H. G., Kahn, R. S., & Hulshoff Pol, H. E. (2012) · Human Brain Mapping · doi:10.1002/hbm.21334 · Cited by 484
Self-citationOlabi, B., Ellison-Wright, I., McIntosh, A. M., Wood, S. J., Bullmore, E., & Lawrie, S. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.032 · Cited by 483
Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies
Marsman, A., van den Heuvel, M. P., Klomp, D. W. J., Kahn, R. S., Luijten, P. R., & Hulshoff Pol, H. E. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr069 · Cited by 457
Self-citationVita, A., De Peri, L., Deste, G., & Sacchetti, E. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.116 · Cited by 453
Advances in multimodal data fusion in neuroimaging: Overview, challenges, and novel orientation
Zhang, Y.-D., Dong, Z., Wang, S.-H., Yu, X., Yao, X., Zhou, Q., Hu, H., Li, M., Jiménez-Mesa, C., Ramirez, J., et al. (2020) · Information Fusion · doi:10.1016/j.inffus.2020.07.006 · Cited by 453
Vita, A., De Peri, L., Silenzi, C., & Dieci, M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.11.004 · Cited by 397
Salisbury, D. F., Kuroki, N., Kasai, K., Shenton, M. E., & McCarley, R. W. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.521 · Cited by 379
Changes in Cortical Thickness During the Course of Illness in Schizophrenia
van Haren, N. E. M. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.88 · Cited by 378
Self-citationAccelerated Brain Aging in Schizophrenia: A Longitudinal Pattern Recognition Study
Schnack, H. G., van Haren, N. E. M., Nieuwenhuis, M., Hulshoff Pol, H. E., Cahn, W., & Kahn, R. S. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15070922 · Cited by 374
Self-citationAndreasen, N. C., Nopoulos, P., Magnotta, V., Pierson, R., Ziebell, S., & Ho, B.-C. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.05.017 · Cited by 373
Hulshoff Pol, H. E., & Kahn, R. S. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm168 · Cited by 364
Self-citationMapping Cortical Thickness and Gray Matter Concentration in First Episode Schizophrenia
Narr, K. L., Bilder, R. M., Toga, A. W., Woods, R. P., Rex, D. E., Szeszko, P. R., Robinson, D., Sevy, S., Gunduz-Bruce, H., Wang, Y.-P., et al. (2005) · Cerebral Cortex · doi:10.1093/cercor/bhh172 · Cited by 358
Andreasen, N. C., Liu, D., Ziebell, S., Vora, A., & Ho, B.-C. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12050674 · Cited by 352
Brain Volumes in Relatives of Patients With Schizophrenia: A Meta-analysis
Boos, H. B. M., Aleman, A., Cahn, W., Pol, H. H., & Kahn, R. S. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.297 · Cited by 344
Self-citationDo antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings
Navari, S., & Dazzan, P. (2009) · Psychological Medicine · doi:10.1017/s0033291709005315 · Cited by 336
The Myth of Schizophrenia as a Progressive Brain Disease
Zipursky, R. B., Reilly, T. J., & Murray, R. M. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs135 · Cited by 334
A systematic review of longitudinal outcome studies of first-episode psychosis
MENEZES, N. M., ARENOVICH, T., & ZIPURSKY, R. B. (2006) · Psychological Medicine · doi:10.1017/s0033291706007951 · Cited by 333
Progressive Gray Matter Reduction of the Superior Temporal Gyrus During Transition to Psychosis
Takahashi, T., Wood, S. J., Yung, A. R., Soulsby, B., McGorry, P. D., Suzuki, M., Kawasaki, Y., Phillips, L. J., Velakoulis, D., & Pantelis, C. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.12 · Cited by 328
van Haren, N. E. M., Hulshoff Pol, H. E., Schnack, H. G., Cahn, W., Mandl, R. C. W., Collins, D. L., Evans, A. C., & Kahn, R. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301347 · Cited by 311
Self-citationA systematic review of the effects of antipsychotic drugs on brain volume
Moncrieff, J., & Leo, J. (2010) · Psychological Medicine · doi:10.1017/s0033291709992297 · Cited by 309
Schizophrenia: Etiology and Course
Walker, E., Kestler, L., Bollini, A., & Hochman, K. M. (2004) · Annual Review of Psychology · doi:10.1146/annurev.psych.55.090902.141950 · Cited by 297
Apoptotic mechanisms and the synaptic pathology of schizophrenia
Glantz, L. A., Gilmore, J. H., Lieberman, J. A., & Jarskog, L. F. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.014 · Cited by 292
van Haren, N. E. M., Pol, H. E. H., Schnack, H. G., Cahn, W., Brans, R., Carati, I., Rais, M., & Kahn, R. S. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.01.004 · Cited by 276
Self-citationVita, A., De Peri, L., Deste, G., Barlati, S., & Sacchetti, E. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.02.008 · Cited by 275
Ehrenreich, H., Hinze-Selch, D., Stawicki, S., Aust, C., Knolle-Veentjer, S., Wilms, S., Heinz, G., Erdag, S., Jahn, H., Degner, D., et al. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001907 · Cited by 258
What causes the onset of psychosis?
Broome, M. R., Woolley, J. B., Tabraham, P., Johns, L. C., Bramon, E., Murray, G. K., Pariante, C., McGuire, P. K., & Murray, R. M. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.02.007 · Cited by 207
Vernon, A. C., Natesan, S., Modo, M., & Kapur, S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.11.010 · Cited by 173
Brunelin, J., Poulet, E., Bediou, B., Kallel, L., Dalery, J., D'amato, T., & Saoud, M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.009 · Cited by 151
Heritability of Changes in Brain Volume Over Time in Twin Pairs Discordant for Schizophrenia
Brans, R. G. H., van Haren, N. E. M., van Baal, G. C. M., Schnack, H. G., Kahn, R. S., & Pol, H. E. H. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.11.1259 · Cited by 129
Self-citationGogtay, N. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm103 · Cited by 124
Ohrmann, P., Siegmund, A., Suslow, T., Pedersen, A., Spitzberg, K., Kersting, A., Rothermundt, M., Arolt, V., Heindel, W., & Pfleiderer, B. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.07.002 · Cited by 116
Gamma oscillation deficits and the onset and early progression of schizophrenia
Woo, T.-U. W., Spencer, K., & McCarley, R. W. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673221003747609 · Cited by 96
Yoshida, T., McCarley, R. W., Nakamura, M., Lee, K., Koo, M.-S., Bouix, S., Salisbury, D. F., Morra, L., Shenton, M. E., & Niznikiewicz, M. A. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.05.004 · Cited by 74
The potential role of lamotrigine in schizophrenia
Large, C. H., Webster, E. L., & Goff, D. C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0020-9 · Cited by 69
Hippocampal volume as marker of daily life stress sensitivity in psychosis
Collip, D., Habets, P., Marcelis, M., Gronenschild, E., Lataster, T., Lardinois, M., Nicolson, N. A., & Myin-Germeys, I. (2013) · Psychological Medicine · doi:10.1017/s003329171200219x · Cited by 60
Chaves, C., Marque, C. R., Maia-de-Oliveira, J. P., Wichert-Ana, L., Ferrari, T. B., Santos, A. C., Araújo, D., Machado-de-Sousa, J. P., Bressan, R. A., Elkis, H., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.11.031 · Cited by 41
Whitford, T. J., Grieve, S. M., Farrow, T. F. D., Gomes, L., Brennan, J., Harris, A. W. F., Gordon, E., & Williams, L. M. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.164.7.1082 · Cited by 99
Metadata
- Authors
- Cahn, W., Pol, H. E. H., Lems, E. B. T. E., van Haren, N. E. M., Schnack, H. G., van der Linden, J. A., Schothorst, P. F., van Engeland, H., & Kahn, R. S.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2002-11-01
- Volume
- 59
- Issue
- 11
- Pages
- 1002
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2018851857
- Cited by
- 400
- References
- 79
- FWCI
- 12.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.